Siemens DCA Vantage Hemoglobin A1C Test Kits, Box (5035C)

The Siemens DCA Vantage Hemoglobin A1C Test Kits, Box of 10 (5035C) deliver accurate HbA1C testing for diabetes management. Compatible with DCA 2000+ and DCA Vantage analyzers, these kits are ideal for point-of-care clinical settings.

Designed for accurate and reliable measurement of HbA1C in diabetes management. These test kits are compatible with both the DCA 2000+ and DCA Vantage analyzers, enabling fast, point-of-care results that support timely treatment decisions.

Each kit provides consistent performance, helping clinicians monitor long-term glycemic control in patients with diabetes. The convenient box of 10 ensures clinical efficiency while supporting infection control standards.

Key Features:

• Accurate Hemoglobin A1C (HbA1C) testing for diabetes management

• Compatible with DCA 2000+ and DCA Vantage analyzers

• Box of 10 test kits for clinical efficiency

• Supports point-of-care testing for immediate results

• Reliable, consistent performance for patient care

Ideal For: Physician offices, diabetes clinics, outpatient facilities, and any point-of-care setting requiring accurate HbA1C measurement and diabetes monitoring.

The Siemens DCA Vantage Analyzer, also known as the DCA Vantage HbA1c Analyzer, is a trusted point‑of‑care testing system designed to deliver fast, accurate, and clinically actionable results for diabetes management. Built for physician offices, clinics, community health centers, and hospital outpatient departments, the DCA Vantage System streamlines HbA1c and microalbumin testing with laboratory‑quality precision and minimal operator training.

The DCA Vantage System is CLIA‑waived for HbA1c testing, enabling providers to perform real‑time diabetes monitoring during a single patient visit. This dramatically improves care efficiency by eliminating the delays associated with sending samples to an outside laboratory. With results available in as little as 6 minutes, clinicians can adjust treatment plans immediately, improving patient engagement and long‑term glycemic control.

Engineered for reliability, the Siemens DCA Vantage Analyzer uses sealed, reagent‑integrated cartridges that reduce handling errors and ensure consistent performance. Its intuitive touchscreen interface, onboard prompts, and automatic calibration make it easy for staff to operate, even in high‑volume environments. The analyzer also stores thousands of patient results, supports barcode scanning, and integrates seamlessly with LIS/EMR systems for streamlined documentation.

The DCA Vantage HbA1c Analyzer is widely recognized for its accuracy, meeting NGSP certification and IFCC traceability standards. It is also capable of performing ACR (Albumin‑to‑Creatinine Ratio) testing, giving providers a comprehensive tool for monitoring both glycemic control and early kidney disease—two critical components of diabetes management.

Whether you are upgrading your diagnostic workflow or expanding your point‑of‑care testing capabilities, the Siemens DCA Vantage System delivers dependable performance, reduced turnaround time, and improved clinical decision‑making. Its compact footprint, user‑friendly design, and proven accuracy make it one of the most trusted HbA1c analyzers in modern healthcare.

Q & A

Q: What tests can the Siemens DCA Vantage Analyzer perform?

The system performs HbA1c testing (CLIA‑waived) and Albumin‑to‑Creatinine Ratio (ACR) testing for early kidney disease detection.

Q: How long does an HbA1c test take on the DCA Vantage System?

HbA1c results are available in approximately 6 minutes, enabling same‑visit clinical decisions.

Q: Is the DCA Vantage HbA1c Analyzer easy for staff to use?

Yes. Its touchscreen interface, automated calibration, and cartridge‑based workflow make it simple for both new and experienced operators.

Q: Does the analyzer connect to EMR or LIS systems?

Absolutely. The DCA Vantage System supports connectivity for seamless result integration into electronic medical records.

Q: Is the Siemens DCA Vantage Analyzer accurate enough for clinical decision‑making?

Yes. It meets NGSP and IFCC standards, ensuring laboratory‑quality accuracy at the point of care.